Shanghai Henlius Biotech Inc - ESG Rating & Company Profile powered by AI
If you are employed by Shanghai Henlius Biotech Inc and you wish to use your ESG rating, please contact us. Alternative corporations in the scoring peer group for Shanghai Henlius Biotech Inc are displayedin the table. The analysis of Shanghai Henlius Biotech Inc was assembled by All Street Sevva using proprietary machine learning.
Shanghai Henlius Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Shanghai Henlius Biotech Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Shanghai Henlius Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc offer flexible work?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose water use targets?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Shanghai Henlius Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Shanghai Henlius Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Shanghai Henlius Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes Shanghai Henlius Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Shanghai Henlius Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Shanghai Henlius Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
Shanghai Henlius Biotech, Inc., a biopharmaceutical company, engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases. It offers HANLIKANG, a rituximab injection for treating non-hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis; HANQUYOU, a trastuzumab injection to treat breast and metastatic gastric cancer; HANDAYUAN, an adalimumab injection for the treatment of rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, and uveitis; HANBEITAI, a bevacizumab injection to treat metastatic colorectal cancer (mCRC) and non-squamous non-small cell lung cancer (nsNSCLC); and HANSIZHUANG, a serplulimab injection for microsatellite instability-high solid tumors. The company also develops Serplulimab to treat squamous non-small cell lung cancer (sqNSCLC), extensive small-cell lung cancer, metastatic esophageal squamous-cell carcinomas, neo-/adjuvant treatment of gastric cancer, hepatocellular carcinoma, mCRC, nsNSCLC, squamous cell carcinoma of the head and neck (SCCHN), and solid tumors; HLX04-O, a bevacizumab injection for wet age-related macular degeneration; HLX22 to treat breast and metastatic gastric cancer; HLX07, HLX23, HLX35, HLX208, HLX55, HLX301, and HLX20 for the treatment of solid tumors; HLX11 to treat breast cancer; HLX05, a cetuximab injection for mCRC and SCCHN; HLX12 for gastric cancer, metastatic non-small cell lung cancer, and mCRC; and HLX14 to treat osteoporosis. In addition, it develops HLX26 for the treatment of solid tumor and lymphoma; HLX13 to treat melanoma, renal cell carcinoma, and mCRC; HLX15 for multiple myeloma; and HLX71 to treat COVID-19. Shanghai Henlius Biotech, Inc. operates in Mainland China, Europe, rest of Asia Pacific, and internationally. The company was founded in 2010 and is headquartered in Shanghai, China. Shanghai Henlius Biotech, Inc. is a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.